Skip to the page

Data / Form D filings / Penrhos Bio Ltd

Penrhos Bio Ltd: Form D filing

Penrhos Bio Ltd, a technology company in London, United Kingdom, filed a Form D with the SEC in 2023. The latest, on September 1, 2023, reports $281,860 sold of an offering with no set size to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
FINSGATE 5-7 CRANWOOD STREET, London, United Kingdom, EC1V
Phone
(212) 451-2300
Industry
Other Technology
Entity type
Other (England and Wales, private limited company)
Incorporated in
United Kingdom
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1991464

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 1, 2023New noticeIndefinite$281,8602Jun 15, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
STEVEN A. HOWELLDirector
NEIL J. PARRYDirector
JONATHAN A. HAGUEDirector
RICHARD A. HAMMONDExecutive Officer, Director
PAUL A. P. FOULGERDirector
YVONNE A. DAVIESDirector

Every Form D from the week of Aug 28, 2023 · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Penrhos Bio Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.